THY has been proven to be a cancer marker [45], and it has been found that high expression of THY1 is linked to poor prognosis in individuals with extrahepatic cholangiocarcinoma [46] and lung cancer patients [47]. The gene discussed is THY1; the disease is lung carcinoma.